Octavio Espinoza
Chief Financial Officer at Ligand Pharmaceuticals · 6 reported transactions in 1 company · latest trade Aug 12, 2026
Their trades
Sold | Aug 12, 2026 | Aug 12, 2026 close $293.27 → Oct 29, 2026 close $317.33. S&P 500 −0.0% over the same days. |
$9.24M
Aug 12, 2026 close $293.27 → Oct 29, 2026 close $317.33. S&P 500 −0.0% over the same days.